Lysogene announced the changes to the composition of its Board of Directors. Philippe Goupit is joining Lysogene as an independent director. Philippe currently sits on the Board of Directors of MedDay Pharmaceuticals, a pioneer in developing therapies for central nervous system disorders. Philippe has replaced Rafaèle Tordjman on the Board of Directors with effect from October 25, 2018 and has also been appointed a member of the Audit Committee. Lysogene is also announcing the departure of Philippe Mendels-Flandre, who joined the company as Chief Operating Officer and is leaving to pursue a new venture.